5.75
price down icon0.17%   -0.010
after-market Handel nachbörslich: 5.77 0.02 +0.35%
loading
Schlusskurs vom Vortag:
$5.76
Offen:
$6.53
24-Stunden-Volumen:
22,112
Relative Volume:
0.83
Marktkapitalisierung:
$9.46M
Einnahmen:
$770.00K
Nettoeinkommen (Verlust:
$-38.84M
KGV:
-0.4048
EPS:
-14.2049
Netto-Cashflow:
$-43.02M
1W Leistung:
-4.64%
1M Leistung:
-17.86%
6M Leistung:
+6.19%
1J Leistung:
-55.58%
1-Tages-Spanne:
Value
$5.66
$6.53
1-Wochen-Bereich:
Value
$5.52
$6.53
52-Wochen-Spanne:
Value
$3.8101
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Firmenname
Lyra Therapeutics Inc
Name
Telefon
617-373-4600
Name
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Name
Mitarbeiter
30
Name
Twitter
@LyraTx
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
LYRA's Discussions on Twitter

Vergleichen Sie LYRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LYRA
Lyra Therapeutics Inc
5.75 9.47M 770.00K -38.84M -43.02M -14.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Herabstufung BofA Securities Buy → Underperform
2024-05-07 Herabstufung H.C. Wainwright Buy → Neutral
2024-05-07 Herabstufung Jefferies Buy → Hold
2024-05-06 Herabstufung William Blair Outperform → Mkt Perform
2023-10-06 Fortgesetzt BTIG Research Buy
2023-08-31 Eingeleitet H.C. Wainwright Buy
2022-05-24 Eingeleitet Cantor Fitzgerald Overweight
2020-05-26 Eingeleitet BTIG Research Buy
2020-05-26 Eingeleitet BofA/Merrill Buy
2020-05-26 Eingeleitet Jefferies Buy
2020-05-26 Eingeleitet William Blair Outperform
Alle ansehen

Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten

pulisher
Nov 03, 2025

How Lyra Therapeutics Inc. stock benefits from global expansionJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What technical charts say about Lyra Therapeutics Inc. stockWeekly Risk Summary & Daily Profit Focused Screening - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Price momentum metrics for Lyra Therapeutics Inc. explainedJuly 2025 Spike Watch & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Lyra Therapeutics Inc. outperform the marketDividend Hike & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to escape a deep drawdown in Lyra Therapeutics Inc.Rate Cut & Free Fast Gain Swing Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What machine learning models say about Lyra Therapeutics Inc.Portfolio Profit Report & Fast Gain Swing Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Lyra Therapeutics Inc. stock see insider buyingPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Lyra Therapeutics Inc. stock overvalued by current metricsWeekly Stock Summary & Daily Stock Trend Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stockInsider Buying & Reliable Momentum Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What indicators show strength in Lyra Therapeutics Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Identifying reversal signals in Lyra Therapeutics Inc.M&A Rumor & High Conviction Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Order flow analysis tools used on Lyra Therapeutics Inc.July 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Risk adjusted return profile for Lyra Therapeutics Inc. analyzedJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will earnings trigger a reversal in Lyra Therapeutics Inc.July 2025 Short Interest & Proven Capital Preservation Methods - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Cash from operating activities of Lyra Therapeutics, Inc. – BOATS:LYRA - TradingView

Nov 01, 2025
pulisher
Oct 31, 2025

Is Lyra Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Gains Report & Verified Swing Trading Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Lyra Therapeutics Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Lyra Therapeutics Inc. still worth holding after the dipRate Hike & Low Drawdown Investment Strategies - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Why Lyra Therapeutics Inc. stock could see breakout soonGlobal Markets & Expert Curated Trade Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What is the Price Targets for Lyra Therapeutics Inc (LYRA)? - fostersleader.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Lyra Therapeutics Inc. stock a bargain at current levelsFed Meeting & Daily Risk Controlled Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 21:52:23 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

How Lyra Therapeutics Inc. stock responds to policy changesPortfolio Performance Summary & Daily Stock Trend Watchlist - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Aug Selloffs: Is Lyra Therapeutics Inc. stock a bargain at current levelsJuly 2025 Volume & AI Driven Stock Price Forecasts - Fundação Cultural do Pará

Oct 28, 2025

Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):